chromatography was performed on silica gel 60 F254 aluminum-backed plates fabricated by Merck. Flash column chromatography was performed on silica gel 60 (40-63 μm) produced by Merck. NMR spectra were recorded on a Bruker AVI600, Bruker AVII400 or a Bruker DPX300 spectrometer at 600 MHz, 400 MHz or 300 MHz respectively for 1 H NMR and at 150 MHz, 100 MHz or 75 MHz respectively for 13 C NMR. Coupling constants (J) are reported in hertz and chemical shifts are reported in parts per million (δ) relative to the central residual protium solvent resonance in 1 H NMR (CDCl3 = δ 7.26, DMSO-d6 = δ 2.50 and MeOD = δ 3.31) and the central carbon solvent resonance in 13 C NMR (CDCl3 = δ 77.00 ppm, DMSO-d6 = δ 39.43 and MeOD = δ 49.00). Optical rotations were measured using a 1 mL cell with a 1.0 dm path length on a Perkin Elmer 341 polarimeter. Mass spectra were recorded at 70 eV on Micromass Prospec Q or Micromass QTOF 2 W spectrometer using ESI as the method of ionization. High-resolution mass spectra were recorded at 70 eV on Micromass Prospec Q or Micromass QTOF 2W spectrometer using ESI as the method of ionization. HPLC-analyses were performed using a C18 stationary phase (Eclipse XDB-C18, 4.6 x 250 mm, particle size 5 μm, from Agilent Technologies), applying the conditions stated. The UV-VIS spectra were recorded using an Agilent Technologies Cary 8485 UV-VIS spectrophotometer using quartz cuvettes.
Experimental Details (S)-4-isopropylthiazolidine-2-thione (14)
Nagao's chiral auxiliary 14, was prepared from commercially available (S)-(+)-2-amino-3-methyl-1butanol (13) as previously reported in the literature. [1] [2] Yield: 67% over the two steps. All spectroscopic and physical data were in agreement with those reported in the literature. 2 TLC (hexane/Et2O 9:1, KMnO4-stain) Rf = 0.25.
(R,4E,6E)-7-bromo-3-((tert-butyldimethylsilyl)oxy)-1-((R)-4-isopropyl-2-thioxothiazolidin-3yl)hepta-4,6-dien-1-one (19)
Thiazolidinethione 19 was prepared in four steps from commercially available pyridinium-1-sulfonate 15 as previously reported in the literature. [3] [4] [5] [6] Yield: 28% over the four steps. All spectroscopic and physical data were in agreement with those reported in the literature. 6 
(S)-3-((tert-butyldimethylsilyl)oxy)pent-4-yn-1-ol (21)
To a solution of TBS-lactone 20 (1.50 g, 6.90 mmol, 1.00 equiv.) in CH2Cl2 (75 mL 
(S)-3-((tert-butyldimethylsilyl)oxy)pent-4-ynal (7)
Alcohol 21 (529 mg, 2.47 mmol, 1.00 equiv.) dissolved in dry CH2Cl2 (22 mL) was added Dess-Martin periodinane (1.27 g, 2.99 mmol, 1.21 equiv.) and NaHCO3 (s) (972 mg, 11.6 mmol, 4.69 equiv.). After 6 hours, the reaction mixture was quenched with a saturated solution of Na2S2O3 (aq) (16 mL) and NaHCO3 (aq) (16 mL). The layers were separated and the aqueous layer was extracted with Et2O (3 × 10 mL). The combined organic extracts were washed with brine (10 mL) dried (Na2SO4) and concentrated in vacuo. The crude product was passed through a silica plug with hexane/EtOAc 8:2 as eluent to afford the title compound 7 as a colorless oil. Yield: 515 mg (98%). All spectroscopic and physical data were in agreement with those reported in the literature. 
Methyl (R,7Z,11E,13E)-14-bromo-10-((tert-butyldimethylsilyl)oxy)tetradeca-7,11,13-trienoate (9)
Following the procedure reported by Olivo and coworkers, 8 the protected thiazolidinethione 19 (578 mg, 1.21 mmol, 1.00 equiv.) was dissolved in CH2Cl2 (23 mL) followed by dropwise addition of DIBAL-H (1.0 M in CH2Cl2, 1.45 mmol, 1.20 equiv.) at -78 °C. After three h., additional DIBAL-H was added (1.0 M in CH2Cl2, 0.240 mmol, 0.198 equiv.). The mixture was allowed to stir for 30 min and then quenched with saturated NaHCO3 (aq) (14 mL). The cooling bath was removed and solid Na-K tartrate (~ 0.400 g) (Rochelle salt) was added and stirring was continued for another 45 min. Et2O (35 mL) was added. The layers were separated and the aq. layer was extracted with Et2O (3 × 30 mL). The combined organic layers were dried (Na2SO4) and concentrated in vacuo. The residue was purified by column chromatography on silica gel (hexane/EtOAc 95:5) Rf = 0.24, and concentrated in vacuo, but not to dryness. Commercially available Wittig salt 23 (670 mg, 1.26 mmol, 1.00 equiv.) in THF (16 mL) and HMPA (1.7 mL) was slowly added NaHMDS (0.6 M in THF, 2.1 mL, 1.04 equiv.) at -78 °C and then stirred for 15 min at 0 °C. The purified aldehyde 22 was added. The solution was allowed to slowly warm up to room temperature in the dry ice/acetone bath for 24 h before it was quenched with phosphate buffer (12 mL, pH = 7.2). Et2O (15 mL) was added and the phases were separated. The aqueous phase was extracted with Et2O (2 × 15 mL) and the combined organic layers were dried (Na2SO4), before concentrated in vacuo. The crude product was purified by column chromatography on silica (hexane/EtOAc 95:5) to afford the title compound 9 as a clear oil. Yield: 386 mg (45-72% over two steps). All spectroscopic and physical data were in agreement with those reported in the literature. 9 
Lipid Mediator Metabololipidomics
Matching of synthetic 5 with endogenous products was conducted as previously reported. 10 Summarily, biological samples were subject to C18 solid-phase extraction. Prior to sample extraction, d4-LTB4, (500 pg), d5-RvE1 (100 pg), were added as internal standards. Extracted samples were analyzed using QTrap 6500+ (ABSciex) MS system, coupled with a Shimadzu SIL-20AC HT autosampler and LC-20AD LC pumps. Agilent C18 Poroshell column (150 mm × 4.6 mm × 2.7 μm) was used to profile lipid mediators.
The gradient was initiated at 20:80:0.01 (vol/vol/vol) methanol/water/acetic acid for 0.2 min this was ramped to 50:50:0.01 (vol/vol/vol) over 12 s, maintained for 2 min, then ramped to 80:20:0.01 (vol/vol/vol) over 9 min, and maintained for 3.5 min. The ratio was then ramped to 98:2:0.01 (vol/vol/vol) for 5.5 min. The flow rate was kept at 0.5 mL/min throughout elution.
Mediator identity was established using multiple reaction monitoring (MRM) using signature parent ion (Q1) and characteristic daughter ion (Q3) pairs to match retention time of the biological material to synthetic material (5) . Then, using an Enhanced Product Ion (EPI) scan a minimum of six diagnostic ions were used to confirm identity, in accordance with published criteria. 10 
Matching of synthetic 22-OH-

